Milestones :: Perspectives :: Research
China: COVID-19 Vaccines – Announcements/Regulatory Actions/Deployment
NMPA holds meeting to review vaccine regulatory quality management system
The National Medical Products Administration (NMPA) held a vaccine regulatory quality management system review meeting on June 15, to summarize the construction and operation of the system, evaluate its appropriateness, effectiveness and adequacy, and make arrangements for the key tasks of the next stage of its construction…
China-UK drug regulatory cooperation project kicks off
The meeting adopted the plan for the China-UK drug regulatory cooperation project in 2021 to push forward technical exchanges in areas of drug review, inspection and post-marketing monitoring for better mutual understanding and deeper cooperation….